BIOS — Bioservo Technologies AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK1.60m
- -SEK17.28m
- SEK9.64m
Annual balance sheet for Bioservo Technologies AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 25.6 | 56.9 | 52.6 | 51.5 | 25 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.76 | 5.8 | 4.57 | 2.81 | 6.49 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 34.2 | 68 | 60.2 | 65.5 | 46.4 |
| Net Property, Plant And Equipment | 0.621 | 0.504 | 0.355 | 0.205 | 0.186 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 50.2 | 81.3 | 70.6 | 73.5 | 52.5 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10.1 | 6 | 7.99 | 10.6 | 14.1 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 10.1 | 6 | 8.3 | 10.8 | 15.1 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 40.1 | 75.3 | 62.3 | 62.8 | 37.5 |
| Total Liabilities & Shareholders' Equity | 50.2 | 81.3 | 70.6 | 73.5 | 52.5 |
| Total Common Shares Outstanding |